Mycophenolate Is Effective in the Treatment of Pemphigus Vulgaris
Open Access
- 1 January 1999
- journal article
- observation
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 135 (1), 54-56
- https://doi.org/10.1001/archderm.135.1.54
Abstract
Background Pemphigus vulgaris is a potentially life-threatening autoimmune disease. Although combination therapies with prednisone and azathioprine are usually effective in controlling the disease, some patients either do not respond to this treatment or show early relapses. Objective To find out whether mycophenolate mofetil would be an effective drug in controlling pemphigus vulgaris in patients who failed initial treatment with azathioprine and prednisone. Results Twelve patients who were initially diagnosed as having pemphigus vulgaris and had relapsed while undergoing treatment with azathioprine (1.5-2 mg/kg of body weight) and prednisolone (2 mg/kg of body weight) subsequently received combination therapy with mycophenolate mofetil (2 × 1 g/d) and prednisolone (2 mg/kg of body weight per day). Eleven of the 12 patients responded to therapy and showed no relapse of their disease even after tapering of the steroid dose. One patient did not respond. Toxic effects were low with only mild gastrointestinal symptoms in 5 patients and mild lymphopenia (World Health Organization grade I) in 9 patients. During the 9- to 12-month follow-up, none of the 11 patients showed reappearance of pemphigus lesions. Conclusion Treatment of pemphigus vulgaris with mycophenolate is a safe and effective treatment.Keywords
This publication has 4 references indexed in Scilit:
- Treatment of pemphigus vulgaris with mycophenolate mofetilThe Lancet, 1997
- Bullous pemphigoid treated with mycophenolate mofetilThe Lancet, 1997
- Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesionCell, 1991
- Pemphigus: a 20-year review of 107 patients treated with corticosteroidsArchives of Dermatology, 1976